Cargando…

The Accessibility of Opioid Agonist Treatment and Its Forced Discontinuation in Swiss Prisons—Attitudes, Perceptions and Experiences of Defense Lawyers in Dealing With Detained Persons Using Opioids

BACKGROUND: Opioid agonist treatment (OAT) is an important pillar in the treatment of individuals using opioids and its continuation during imprisonment is recommended. Despite this knowledge access to and continuation of OAT is still limited in many countries. The forced discontinuation during pre-...

Descripción completa

Detalles Bibliográficos
Autores principales: Buadze, Anna, Baggio, Stephanie, Schleifer, Roman, Aeberhard, Eveline, Wolff, Hans, Schneeberger, Andres, Liebrenz, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240251/
https://www.ncbi.nlm.nih.gov/pubmed/32477183
http://dx.doi.org/10.3389/fpsyt.2020.00395
_version_ 1783536842667196416
author Buadze, Anna
Baggio, Stephanie
Schleifer, Roman
Aeberhard, Eveline
Wolff, Hans
Schneeberger, Andres
Liebrenz, Michael
author_facet Buadze, Anna
Baggio, Stephanie
Schleifer, Roman
Aeberhard, Eveline
Wolff, Hans
Schneeberger, Andres
Liebrenz, Michael
author_sort Buadze, Anna
collection PubMed
description BACKGROUND: Opioid agonist treatment (OAT) is an important pillar in the treatment of individuals using opioids and its continuation during imprisonment is recommended. Despite this knowledge access to and continuation of OAT is still limited in many countries. The forced discontinuation during pre-trial detention can cause severe withdrawal symptoms, which in turn may significantly impair the defendant's ability to exercise granted procedural participation rights. Furthermore, it can be argued that forced discontinuation of a desired treatment represents a form of a compulsory intervention. AIMS: The present study was developed against the backdrop of a recent ruling by the European Court of Human Rights (Wenner vs. Germany). It intended to examine how defense lawyers dealing with detained persons using opioids view and assess the accessibility of OAT in pre-trial detention as well as during imprisonment in different parts of Switzerland. METHODS: Using a qualitative approach, we interviewed 11 defense lawyers from three different cantons of Switzerland with multiple years of experience in providing legal representation to more than 220 defendants using heroin. The interviews were analyzed with QSR NVIVO 11 for Windows. A qualitative content analysis approach was used to evaluate findings. RESULTS: Defenders who had been exposed to the opioid crisis during the course of their legal career had adopted a positive attitude towards OAT and associated it with a stabilizing influence on their clients, an improvement in criminal prognosis, and a reduction in recidivism. They were generally of the opinion that access to OAT had improved, however identified a considerable variance in different penitentiaries, which were mediated by attitudes of staff and authorities. Based on the assessments of the defense lawyers, it can be estimated that the initiation of OAT especially during pre-trial detention is challenging. The predominant aim of OAT in a variety of Swiss prisons still seems to focus on a discontinuation, mediated by a forced reduction of medication. Some of the interventions reported are not in line with the principle of equivalence and strongly contrast the recommendations of the Council of Europe.
format Online
Article
Text
id pubmed-7240251
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-72402512020-05-29 The Accessibility of Opioid Agonist Treatment and Its Forced Discontinuation in Swiss Prisons—Attitudes, Perceptions and Experiences of Defense Lawyers in Dealing With Detained Persons Using Opioids Buadze, Anna Baggio, Stephanie Schleifer, Roman Aeberhard, Eveline Wolff, Hans Schneeberger, Andres Liebrenz, Michael Front Psychiatry Psychiatry BACKGROUND: Opioid agonist treatment (OAT) is an important pillar in the treatment of individuals using opioids and its continuation during imprisonment is recommended. Despite this knowledge access to and continuation of OAT is still limited in many countries. The forced discontinuation during pre-trial detention can cause severe withdrawal symptoms, which in turn may significantly impair the defendant's ability to exercise granted procedural participation rights. Furthermore, it can be argued that forced discontinuation of a desired treatment represents a form of a compulsory intervention. AIMS: The present study was developed against the backdrop of a recent ruling by the European Court of Human Rights (Wenner vs. Germany). It intended to examine how defense lawyers dealing with detained persons using opioids view and assess the accessibility of OAT in pre-trial detention as well as during imprisonment in different parts of Switzerland. METHODS: Using a qualitative approach, we interviewed 11 defense lawyers from three different cantons of Switzerland with multiple years of experience in providing legal representation to more than 220 defendants using heroin. The interviews were analyzed with QSR NVIVO 11 for Windows. A qualitative content analysis approach was used to evaluate findings. RESULTS: Defenders who had been exposed to the opioid crisis during the course of their legal career had adopted a positive attitude towards OAT and associated it with a stabilizing influence on their clients, an improvement in criminal prognosis, and a reduction in recidivism. They were generally of the opinion that access to OAT had improved, however identified a considerable variance in different penitentiaries, which were mediated by attitudes of staff and authorities. Based on the assessments of the defense lawyers, it can be estimated that the initiation of OAT especially during pre-trial detention is challenging. The predominant aim of OAT in a variety of Swiss prisons still seems to focus on a discontinuation, mediated by a forced reduction of medication. Some of the interventions reported are not in line with the principle of equivalence and strongly contrast the recommendations of the Council of Europe. Frontiers Media S.A. 2020-05-14 /pmc/articles/PMC7240251/ /pubmed/32477183 http://dx.doi.org/10.3389/fpsyt.2020.00395 Text en Copyright © 2020 Buadze, Baggio, Schleifer, Aeberhard, Wolff, Schneeberger and Liebrenz http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Buadze, Anna
Baggio, Stephanie
Schleifer, Roman
Aeberhard, Eveline
Wolff, Hans
Schneeberger, Andres
Liebrenz, Michael
The Accessibility of Opioid Agonist Treatment and Its Forced Discontinuation in Swiss Prisons—Attitudes, Perceptions and Experiences of Defense Lawyers in Dealing With Detained Persons Using Opioids
title The Accessibility of Opioid Agonist Treatment and Its Forced Discontinuation in Swiss Prisons—Attitudes, Perceptions and Experiences of Defense Lawyers in Dealing With Detained Persons Using Opioids
title_full The Accessibility of Opioid Agonist Treatment and Its Forced Discontinuation in Swiss Prisons—Attitudes, Perceptions and Experiences of Defense Lawyers in Dealing With Detained Persons Using Opioids
title_fullStr The Accessibility of Opioid Agonist Treatment and Its Forced Discontinuation in Swiss Prisons—Attitudes, Perceptions and Experiences of Defense Lawyers in Dealing With Detained Persons Using Opioids
title_full_unstemmed The Accessibility of Opioid Agonist Treatment and Its Forced Discontinuation in Swiss Prisons—Attitudes, Perceptions and Experiences of Defense Lawyers in Dealing With Detained Persons Using Opioids
title_short The Accessibility of Opioid Agonist Treatment and Its Forced Discontinuation in Swiss Prisons—Attitudes, Perceptions and Experiences of Defense Lawyers in Dealing With Detained Persons Using Opioids
title_sort accessibility of opioid agonist treatment and its forced discontinuation in swiss prisons—attitudes, perceptions and experiences of defense lawyers in dealing with detained persons using opioids
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240251/
https://www.ncbi.nlm.nih.gov/pubmed/32477183
http://dx.doi.org/10.3389/fpsyt.2020.00395
work_keys_str_mv AT buadzeanna theaccessibilityofopioidagonisttreatmentanditsforceddiscontinuationinswissprisonsattitudesperceptionsandexperiencesofdefenselawyersindealingwithdetainedpersonsusingopioids
AT baggiostephanie theaccessibilityofopioidagonisttreatmentanditsforceddiscontinuationinswissprisonsattitudesperceptionsandexperiencesofdefenselawyersindealingwithdetainedpersonsusingopioids
AT schleiferroman theaccessibilityofopioidagonisttreatmentanditsforceddiscontinuationinswissprisonsattitudesperceptionsandexperiencesofdefenselawyersindealingwithdetainedpersonsusingopioids
AT aeberhardeveline theaccessibilityofopioidagonisttreatmentanditsforceddiscontinuationinswissprisonsattitudesperceptionsandexperiencesofdefenselawyersindealingwithdetainedpersonsusingopioids
AT wolffhans theaccessibilityofopioidagonisttreatmentanditsforceddiscontinuationinswissprisonsattitudesperceptionsandexperiencesofdefenselawyersindealingwithdetainedpersonsusingopioids
AT schneebergerandres theaccessibilityofopioidagonisttreatmentanditsforceddiscontinuationinswissprisonsattitudesperceptionsandexperiencesofdefenselawyersindealingwithdetainedpersonsusingopioids
AT liebrenzmichael theaccessibilityofopioidagonisttreatmentanditsforceddiscontinuationinswissprisonsattitudesperceptionsandexperiencesofdefenselawyersindealingwithdetainedpersonsusingopioids
AT buadzeanna accessibilityofopioidagonisttreatmentanditsforceddiscontinuationinswissprisonsattitudesperceptionsandexperiencesofdefenselawyersindealingwithdetainedpersonsusingopioids
AT baggiostephanie accessibilityofopioidagonisttreatmentanditsforceddiscontinuationinswissprisonsattitudesperceptionsandexperiencesofdefenselawyersindealingwithdetainedpersonsusingopioids
AT schleiferroman accessibilityofopioidagonisttreatmentanditsforceddiscontinuationinswissprisonsattitudesperceptionsandexperiencesofdefenselawyersindealingwithdetainedpersonsusingopioids
AT aeberhardeveline accessibilityofopioidagonisttreatmentanditsforceddiscontinuationinswissprisonsattitudesperceptionsandexperiencesofdefenselawyersindealingwithdetainedpersonsusingopioids
AT wolffhans accessibilityofopioidagonisttreatmentanditsforceddiscontinuationinswissprisonsattitudesperceptionsandexperiencesofdefenselawyersindealingwithdetainedpersonsusingopioids
AT schneebergerandres accessibilityofopioidagonisttreatmentanditsforceddiscontinuationinswissprisonsattitudesperceptionsandexperiencesofdefenselawyersindealingwithdetainedpersonsusingopioids
AT liebrenzmichael accessibilityofopioidagonisttreatmentanditsforceddiscontinuationinswissprisonsattitudesperceptionsandexperiencesofdefenselawyersindealingwithdetainedpersonsusingopioids